Phenylglyoxal

Phenylglyoxal

SCHEMBL23748334

O=CC(=O)c1ccccc1.c1c[nH]nn1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ AKT1 P31749 2/20 0.40
▸ NFE2L2 Q16236 1/20 0.39
▸ RAB9A P51151 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 3/20 0.37
▸ RECQL P46063 2/20 0.37
▸ PLIN1 O60240 2/20 0.37
▸ PLIN5 Q00G26 2/20 0.37
▸ ABHD5 Q8WTS1 2/20 0.37
▸ CYP1B1 Q16678 2/20 0.37
▸ BCHE P06276 1/20 0.37
▸ TNFRSF1A P19438 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL17495601 0.82 NAPRT (0.54) ALDH1A1LMNAMEN1KMT2ATP53
Benzophenone SCHEMBL27762502 0.82 ALDH1A1 (0.54) ALDH1A1TDP1RAB9AMAPTLMNA
Chalcone SCHEMBL28113459 0.81 CYP1B1 (0.65) ALDH1A1TDP1RAB9AMAPTLMNA
Chalcone SCHEMBL27969784 0.81 CYP1B1 (0.65) ALDH1A1TDP1RAB9AMAPTLMNA
Chalcone SCHEMBL28299193 0.80 CYP1B1 (0.63) ALDH1A1TDP1RAB9AMAPTLMNA
Benzamide SCHEMBL19667939 0.79 POLB (0.57) ALDH1A1TDP1RAB9AMAPTRECQL
Acetophenone SCHEMBL16114519 0.79 SMN1; SMN2 (0.46) ALDH1A1RAB9AMAPTLMNAMAOB
SCHEMBL27970673 0.78 KMT2A (0.33) ALDH1A1LMNAMEN1KMT2AF2
SCHEMBL28061261 0.78 KMT2A (0.33) ALDH1A1LMNAMEN1KMT2AF2
Phenylglyoxal SCHEMBL57493 0.78 ALDH1A1 (1.00) ALDH1A1MAPK1TDP1AKT1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340277-A1 ANTIBODY COMPOUNDS WITH REACTIVE ARGININE AND RELATED ANTIBODY DRUG CONJUGATES THE SCRIPPS RESEARCH INSTITUTE 2021-11-04 — — US disclosed
CN-113329769-A Antibody compounds with reactive arginine and related antibody drug conjugates 斯克里普斯研究学院 2021-08-31 — — CN disclosed
EP-3863672-A1 ANTIBODY COMPOUNDS WITH REACTIVE ARGININE AND RELATED ANTIBODY DRUG CONJUGATES The Scripps Research Institute (US) 2021-08-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340277-A1 ANTIBODY COMPOUNDS WITH REACTIVE ARGININE AND RELATED ANTIBODY DRUG CONJUGATES RAB29, RAB39A, RAB5C ALDH1A1 1868/4885MAPK1 3854/4885TDP1 2913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback